412 related articles for article (PubMed ID: 17320856)
21. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
Hu NW; Smith IM; Walsh DM; Rowan MJ
Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
[TBL] [Abstract][Full Text] [Related]
22. [Effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairments of spatial memory].
Stepanichev MIu; Zdobnova IM; Zarubenko II; Lazareva NA; Guliaeva NV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(5):705-11. PubMed ID: 15573708
[TBL] [Abstract][Full Text] [Related]
23. Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimer's disease.
Tran TT; Srivareerat M; Alkadhi KA
Neurobiol Dis; 2010 Mar; 37(3):756-63. PubMed ID: 20044001
[TBL] [Abstract][Full Text] [Related]
24. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
Tan T; Zhang BL; Tian X
Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel BE; Henkins KM; Parfitt KD
Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol, synaptic function and Alzheimer's disease.
Koudinov AR; Koudinova NV
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S107-12. PubMed ID: 14574623
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
Nomura I; Kato N; Kita T; Takechi H
Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
[TBL] [Abstract][Full Text] [Related]
28. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.
Stéphan A; Laroche S; Davis S
J Neurosci; 2001 Aug; 21(15):5703-14. PubMed ID: 11466442
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease.
Galoyan AA; Sarkissian JS; Chavushyan VA; Meliksetyan IB; Avagyan ZE; Poghosyan MV; Vahradyan HG; Mkrtchian HH; Abrahamyan DO
Alzheimers Dement; 2008 Sep; 4(5):332-44. PubMed ID: 18790460
[TBL] [Abstract][Full Text] [Related]
30. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins.
Yenkoyan K; Safaryan K; Navasardyan G; Mkrtchyan L; Aghajanov M
Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
[TBL] [Abstract][Full Text] [Related]
32. Impaired in vivo synaptic plasticity in dentate gyrus and spatial memory in juvenile rats induced by prenatal morphine exposure.
Niu L; Cao B; Zhu H; Mei B; Wang M; Yang Y; Zhou Y
Hippocampus; 2009 Jul; 19(7):649-57. PubMed ID: 19115391
[TBL] [Abstract][Full Text] [Related]
33. Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats.
Iwasaki K; Egashira N; Hatip-Al-Khatib I; Akiyoshi Y; Arai T; Takagaki Y; Watanabe T; Mishima K; Fujiwara M
Brain Res; 2006 Jun; 1097(1):216-23. PubMed ID: 16729978
[TBL] [Abstract][Full Text] [Related]
34. Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats.
Alvarez XA; Miguel-Hidalgo JJ; Fernández-Novoa L; Cacabelos R
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):471-9. PubMed ID: 9413830
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Exp Gerontol; 2004; 39(11-12):1661-7. PubMed ID: 15582282
[TBL] [Abstract][Full Text] [Related]
36. [Effects of amyloid beta peptide (25-35) on the behavior of rats in a radial maze].
Stepanichev MIu; Moiseeva IuV; Lazareva NA; Guliaeva NV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(3):382-9. PubMed ID: 15326953
[TBL] [Abstract][Full Text] [Related]
37. Memory and learning impairment induced by dexamethasone in senescent but not young mice.
Yao YY; Liu DM; Xu DF; Li WP
Eur J Pharmacol; 2007 Nov; 574(1):20-8. PubMed ID: 17884039
[TBL] [Abstract][Full Text] [Related]
38. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
[TBL] [Abstract][Full Text] [Related]
39. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
40. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.
Cheng L; Yin WJ; Zhang JF; Qi JS
Synapse; 2009 Mar; 63(3):206-14. PubMed ID: 19072840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
